tiprankstipranks
pc:ely3x

Elysium Therapeutics

Elysium Therapeutics is an emerging biopharmaceutical company developing treatments to prevent and reverse overdoses caused by highly potent synthetic opioids, with a specific focus on oral fentanyl and nitazenes. The company is advancing SOOPR™, a rapid-onset, long-acting naloxone prodrug rescue therapy, and developing SMART™ and O2P™ product approaches to improve opioid safety and reduce overdose fatalities.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$8M
Total Amount Raised$8M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$8M
Latest Funding Amount$8M
Latest Funding RoundConvertible Notes
Latest Funding RoundConvertible Notes
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 28, 2026
Convertible Notes
$7.50M

Related News and Analysis